Drug Approval | May 12, 2023
USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology
The survey inspected ambulances operating throughout the city
The session took place in the presence of Union Ministers Hardeep Singh Puri and Gen V K Singh along with Anil Agarwal, Rajya Sabha Member of Parliament
Subscribe To Our Newsletter & Stay Updated
